(1) A PPK must maintain proper storage of all drugs. This includes, but is not limited to the following:
- (a) All drugs must be stored according to manufacturer’s published or USP guidelines.
- (b) All drugs must be stored in appropriate conditions of temperature, light, humidity, sanitation, ventilation, and space.
- (c) Appropriate storage conditions must be provided for, including during transfers between facilities and to patients.
- (d) A PPK must quarantine drugs which are outdated, adulterated, misbranded or suspect.
(2) A PPK must store all drugs at the proper temperature according to manufacturer’s published guidelines (pursuant to FDA package insert or USP guidelines).
(a) All drug refrigeration systems must:
- (A) Maintain refrigerated products between 2 to 8 °C (35.6 to 46.4°F); frozen products between -25 to -10 °C (-13 to 14 °F); or as specified by the manufacturer.
- (B) Utilize a centrally placed, accurate, and calibrated thermometer;
- (C) Be dedicated to pharmaceuticals only;
- (D) Be measured continuously and documented either manually twice daily to include minimum, maximum and current temperatures; or with an automated system capable of creating a producible history of temperature readings.
(b) A PPK must adhere to a monitoring plan, which includes, but is not limited to:
- (A) Documentation of training of all personnel;
- (B) Maintenance of manufacturer recommended calibration of thermometers;
- (C) Maintenance of records of temperature logs for a minimum of three years;
- (D) Documentation of excursion detail, including, but not limited to, event date and name of persons(s) involved in excursion responses;
- (E) Documentation of action(s) taken, including decision to quarantine product for destruction, or determination by a Pharmacist that it is safe for continued use. This documentation must include details of the information source;
- (F) A written emergency action plan;
- (G) Routine preventative maintenance and evaluation of refrigeration equipment and monitoring equipment; and
- (H) Documentation and review of temperature recordings at least once every 28 days by the Pharmacist at the time of in person physical inspection.
Statutory/Other Authority
ORS 689.205 & ORS 689.325
Statutes/Other Implemented
ORS 689.155 & ORS 689.527
History
BP 50-2022, adopt filed 12/20/2022, effective 02/15/2023